Vincent Goffin Selected Research

Prolactin

1/2022	Sex-dependent pain trajectories induced by prolactin require an inflammatory response for pain resolution.
1/2021	Meningeal CGRP-Prolactin Interaction Evokes Female-Specific Migraine Behavior.
12/2019	Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
10/2019	Prolactin Regulates Pain Responses via a Female-Selective Nociceptor-Specific Mechanism.
10/2019	Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
7/2019	STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
1/2019	Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia.
3/2018	17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes.
1/2018	ATM Is Required for the Prolactin-Induced HSP90-Mediated Increase in Cellular Viability and Clonogenic Growth After DNA Damage.
1/2018	Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα+ Mammary Carcinomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Goffin Research Topics

Disease

24	Neoplasms (Cancer) 03/2022 - 04/2003
19	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2005
14	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 05/2005
8	Carcinogenesis 01/2022 - 11/2014
8	Inflammation (Inflammations) 01/2022 - 08/2009
6	Hyperplasia 01/2019 - 09/2003
4	Pain (Aches) 01/2022 - 08/2006
4	Hyperprolactinemia 08/2015 - 10/2006
3	Neoplasm Metastasis (Metastasis) 03/2022 - 07/2007
3	Fibroadenoma 06/2020 - 01/2010
3	Carcinoma (Carcinomatosis) 01/2018 - 08/2006
3	Atherosclerosis 09/2014 - 08/2009
3	Atherosclerotic Plaque (Atheroma) 05/2012 - 08/2009
3	Inborn Genetic Diseases (Disease, Hereditary) 07/2010 - 09/2008
2	Hypertrophy 01/2022 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 12/2019
2	Bites and Stings (Sting) 12/2021 - 11/2016
2	Hyperalgesia 10/2019 - 09/2011
2	Fibrosis (Cirrhosis) 10/2019 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 05/2015 - 04/2014
2	Vascular Diseases (Vascular Disease) 05/2012 - 02/2011
2	Acromegaly 04/2004 - 05/2002
1	Infections 12/2021
1	Genomic Instability 12/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2021
1	Migraine Disorders (Migraine) 01/2021
1	Hypersensitivity (Allergy) 01/2020
1	Chronic Pain 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Adenocarcinoma 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Rheumatic Diseases (Rheumatism) 12/2016
1	Psoriatic Arthritis 12/2016
1	Rheumatoid Arthritis 12/2016
1	Blindness (Hysterical Blindness) 05/2016
1	Disease Progression 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2014

Drug/Important Bio-Agent (IBA)

48	ProlactinIBA 01/2022 - 09/2003
15	Prolactin Receptors (Prolactin Receptor)IBA 01/2020 - 10/2006
9	Hormones (Hormone)IBA 03/2018 - 07/2007
7	AndrogensIBA 01/2022 - 07/2007
5	Phenobarbital (Luminal)FDA Link 03/2022 - 11/2014
5	Pharmaceutical PreparationsIBA 12/2021 - 04/2004
4	Estrogens (Estrogen)FDA Link 01/2022 - 08/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
3	Estrogen ReceptorsIBA 01/2022 - 03/2016
3	CytokinesIBA 12/2021 - 04/2014
3	LigandsIBA 03/2018 - 04/2014
3	CalciumIBA 01/2018 - 09/2014
3	Biological ProductsIBA 07/2010 - 07/2007
3	Dopamine (Intropin)FDA LinkGeneric 07/2010 - 05/2005
2	InterferonsIBA 12/2021 - 01/2013
2	Peptides (Polypeptides)IBA 01/2021 - 12/2006
2	Testosterone (Sustanon)FDA Link 01/2020 - 05/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020 - 10/2019
2	probasinIBA 01/2019 - 01/2015
2	Fulvestrant (Faslodex)FDA Link 03/2018 - 01/2018
2	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2018 - 01/2018
2	Neutralizing AntibodiesIBA 11/2017 - 01/2015
2	Antipsychotic Agents (Antipsychotics)IBA 08/2015 - 10/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2010 - 07/2007
2	pegvisomant FDA LinkGeneric 04/2004 - 05/2002
2	Human Growth Hormone (Saizen)FDA LinkGeneric 04/2004 - 05/2002
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Keratin-7 (Cytokeratin 7)IBA 03/2022
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2022
1	1,1-dimethyl-4-acetylpiperaziniumIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	calcitonin gene-related peptide (8-37)IBA 01/2021
1	Progestins (Progestagens)IBA 06/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	CollagenIBA 10/2019
1	Cre recombinaseIBA 07/2019
1	Protein Isoforms (Isoforms)IBA 03/2018
1	Dietary CalciumIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	TRPC6 Cation ChannelIBA 01/2017
1	Cholecalciferol (Vitamin D3)FDA Link 01/2017
1	Calcium-Sensing ReceptorsIBA 01/2017
1	mafosfamideIBA 11/2016
1	A-Form DNA (A-DNA)IBA 11/2016
1	Sulpiride (neogama)IBA 08/2015
1	saw palmetto extractIBA 05/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	AntigensIBA 11/2014
1	STAT5 Transcription FactorIBA 11/2014
1	LDL Receptors (LDL Receptor)IBA 09/2014
1	LipidsIBA 09/2014

Therapy/Procedure

7	Therapeutics 01/2022 - 08/2010
3	Castration 01/2022 - 11/2014
2	Precision Medicine 01/2022 - 11/2017
2	Drug Therapy (Chemotherapy) 11/2016 - 03/2016
1	Adjuvant Chemotherapy 12/2021
1	Complementary Therapies (Alternative Medicine) 11/2014